By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vectura Limited 

1 Prospect West

Chippenham    SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701



Company News
Mundipharma AG Signs New Deal With Vectura Limited For Global Development And Commercialization Of Inhaled Triple Therapy VR2076 For The Treatment Of Asthma And COPD 12/27/2016 9:16:59 AM
Vectura Limited Pays A Whopping $181 Million For Activaero 3/13/2014 8:18:01 AM
Vectura Limited Gets $7.5 Million as Novartis Corporation (NVS) Starts Key Trial 5/10/2010 11:43:53 AM
Vectura Limited and Sandoz Pharmaceuticals Revise VR315 Agreement; Vectura to Receive $9.5 Million Payment and up to $25 Million Loan Facility 3/18/2010 11:42:12 AM
GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited 3/18/2010 7:03:21 AM
Vectura Limited Revenue Up, Key Drugs to Start Phase III 5/19/2009 7:26:39 AM
Arakis Ltd. And Vectura Group PLC Announce Agreement On New Therapy For Respiratory Disease10/19/2005 5:13:16 PM
Novartis Pharma AG (NVS) In UK Biotech Deal Worth Up To $375 Milllon10/19/2005 5:13:16 PM
SkyePharma Inc. (SKYE) And Vectura Limited Form Strategic Alliance For Pulmonary Delivery Technologies10/19/2005 5:11:35 PM
Vectura, Evolutec File To Try IPO Luck On London Market10/19/2005 5:08:46 PM